The p21 gene is located in the downstream position of the p53 gene in the signal path, and is a cyclin-dependent kinase inhibitor (CDKI); p21 and p53 constitute the G1–S checkpoints, so damaged cells stagnate in the G1 phase to reduce the formation of mutations and thus provide a tumour suppressor effect. The gene discussed is TP53; the disease is neoplasm.